nodes	percent_of_prediction	percent_of_DWPC	metapath
Olopatadine—S100B—artery—metabolic syndrome X	0.122	0.17	CbGeAlD
Olopatadine—S100B—blood vessel—metabolic syndrome X	0.0953	0.132	CbGeAlD
Olopatadine—S100A1—cardiovascular system—metabolic syndrome X	0.0492	0.0683	CbGeAlD
Olopatadine—S100A1—kidney—metabolic syndrome X	0.0481	0.0668	CbGeAlD
Olopatadine—S100A2—adipose tissue—metabolic syndrome X	0.0471	0.0654	CbGeAlD
Olopatadine—S100A13—cardiovascular system—metabolic syndrome X	0.0436	0.0606	CbGeAlD
Olopatadine—S100A1—adipose tissue—metabolic syndrome X	0.0434	0.0602	CbGeAlD
Olopatadine—S100A12—cardiovascular system—metabolic syndrome X	0.0431	0.0598	CbGeAlD
Olopatadine—S100B—cardiovascular system—metabolic syndrome X	0.0425	0.059	CbGeAlD
Olopatadine—S100A13—adipose tissue—metabolic syndrome X	0.0385	0.0534	CbGeAlD
Olopatadine—S100A12—adipose tissue—metabolic syndrome X	0.038	0.0527	CbGeAlD
Olopatadine—S100B—adipose tissue—metabolic syndrome X	0.0375	0.052	CbGeAlD
Olopatadine—S100A13—liver—metabolic syndrome X	0.027	0.0375	CbGeAlD
Olopatadine—S100A12—liver—metabolic syndrome X	0.0266	0.037	CbGeAlD
Olopatadine—S100A2—p73 transcription factor network—SIRT1—metabolic syndrome X	0.0107	0.0588	CbGpPWpGaD
Olopatadine—HRH1—adipose tissue—metabolic syndrome X	0.00769	0.0107	CbGeAlD
Olopatadine—S100A2—p73 transcription factor network—SERPINE1—metabolic syndrome X	0.00665	0.0364	CbGpPWpGaD
Olopatadine—CYP3A4—kidney—metabolic syndrome X	0.00659	0.00915	CbGeAlD
Olopatadine—CYP3A4—Liver X Receptor Pathway—NR1H3—metabolic syndrome X	0.00638	0.0349	CbGpPWpGaD
Olopatadine—S100A12—Toll Like Receptor 4 (TLR4) Cascade—LBP—metabolic syndrome X	0.00615	0.0336	CbGpPWpGaD
Olopatadine—S100B—Toll Like Receptor 4 (TLR4) Cascade—LBP—metabolic syndrome X	0.00582	0.0318	CbGpPWpGaD
Olopatadine—CYP3A4—Liver X Receptor Pathway—SCD—metabolic syndrome X	0.00563	0.0308	CbGpPWpGaD
Olopatadine—S100A12—Toll-Like Receptors Cascades—LBP—metabolic syndrome X	0.00548	0.03	CbGpPWpGaD
Olopatadine—Thiothixene—HTR2C—metabolic syndrome X	0.00525	0.144	CrCbGaD
Olopatadine—S100B—Toll-Like Receptors Cascades—LBP—metabolic syndrome X	0.00518	0.0283	CbGpPWpGaD
Olopatadine—S100A2—Direct p53 effectors—SERPINE1—metabolic syndrome X	0.00421	0.023	CbGpPWpGaD
Olopatadine—CYP3A4—liver—metabolic syndrome X	0.00417	0.00578	CbGeAlD
Olopatadine—Clomipramine—HTR2C—metabolic syndrome X	0.00415	0.114	CrCbGaD
Olopatadine—Chlorprothixene—HTR2C—metabolic syndrome X	0.00413	0.114	CrCbGaD
Olopatadine—Nortriptyline—HTR2C—metabolic syndrome X	0.00405	0.112	CrCbGaD
Olopatadine—CYP3A4—Tamoxifen metabolism—FMO3—metabolic syndrome X	0.00382	0.0209	CbGpPWpGaD
Olopatadine—S100B—Signaling by ERBB4—TRIB3—metabolic syndrome X	0.0037	0.0202	CbGpPWpGaD
Olopatadine—Doxepin—HTR2C—metabolic syndrome X	0.00364	0.1	CrCbGaD
Olopatadine—CYP3A4—Drug Induction of Bile Acid Pathway—NR1I3—metabolic syndrome X	0.00305	0.0167	CbGpPWpGaD
Olopatadine—S100A12—MyD88:Mal cascade initiated on plasma membrane—CD36—metabolic syndrome X	0.00297	0.0162	CbGpPWpGaD
Olopatadine—Imipramine—HTR2C—metabolic syndrome X	0.00283	0.0779	CrCbGaD
Olopatadine—CYP3A4—Liver X Receptor Pathway—SREBF1—metabolic syndrome X	0.00283	0.0155	CbGpPWpGaD
Olopatadine—Amitriptyline—HTR2C—metabolic syndrome X	0.00281	0.0774	CrCbGaD
Olopatadine—S100B—MyD88:Mal cascade initiated on plasma membrane—CD36—metabolic syndrome X	0.00281	0.0154	CbGpPWpGaD
Olopatadine—HRH1—Monoamine GPCRs—HTR2C—metabolic syndrome X	0.0028	0.0153	CbGpPWpGaD
Olopatadine—CYP3A4—Drug Induction of Bile Acid Pathway—NR1I2—metabolic syndrome X	0.00279	0.0153	CbGpPWpGaD
Olopatadine—Nasopharyngitis—Metformin—metabolic syndrome X	0.00275	0.0457	CcSEcCtD
Olopatadine—Influenza—Metformin—metabolic syndrome X	0.00266	0.0441	CcSEcCtD
Olopatadine—S100A12—Activated TLR4 signalling—CD36—metabolic syndrome X	0.00256	0.014	CbGpPWpGaD
Olopatadine—Upper respiratory tract infection—Metformin—metabolic syndrome X	0.00247	0.041	CcSEcCtD
Olopatadine—S100B—Activated TLR4 signalling—CD36—metabolic syndrome X	0.00242	0.0132	CbGpPWpGaD
Olopatadine—S100A12—Toll Like Receptor 4 (TLR4) Cascade—CD36—metabolic syndrome X	0.00241	0.0132	CbGpPWpGaD
Olopatadine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1H3—metabolic syndrome X	0.0024	0.0131	CbGpPWpGaD
Olopatadine—Acepromazine—ALB—metabolic syndrome X	0.00238	0.0655	CrCbGaD
Olopatadine—Infestation—Metformin—metabolic syndrome X	0.00237	0.0393	CcSEcCtD
Olopatadine—Infestation NOS—Metformin—metabolic syndrome X	0.00237	0.0393	CcSEcCtD
Olopatadine—HRH1—Amine ligand-binding receptors—HTR2C—metabolic syndrome X	0.00235	0.0129	CbGpPWpGaD
Olopatadine—Thiothixene—ALB—metabolic syndrome X	0.00229	0.063	CrCbGaD
Olopatadine—S100B—Toll Like Receptor 4 (TLR4) Cascade—CD36—metabolic syndrome X	0.00228	0.0125	CbGpPWpGaD
Olopatadine—S100A12—Toll-Like Receptors Cascades—CD36—metabolic syndrome X	0.00215	0.0117	CbGpPWpGaD
Olopatadine—Rhinitis—Metformin—metabolic syndrome X	0.00213	0.0354	CcSEcCtD
Olopatadine—Hypoaesthesia—Metformin—metabolic syndrome X	0.00212	0.0351	CcSEcCtD
Olopatadine—S100B—Toll-Like Receptors Cascades—CD36—metabolic syndrome X	0.00203	0.0111	CbGpPWpGaD
Olopatadine—Eye disorder—Metformin—metabolic syndrome X	0.00199	0.033	CcSEcCtD
Olopatadine—Immune system disorder—Metformin—metabolic syndrome X	0.00192	0.0319	CcSEcCtD
Olopatadine—Mediastinal disorder—Metformin—metabolic syndrome X	0.00192	0.0318	CcSEcCtD
Olopatadine—Erythema—Metformin—metabolic syndrome X	0.00185	0.0307	CcSEcCtD
Olopatadine—CYP3A4—Constitutive Androstane Receptor Pathway—NR1I3—metabolic syndrome X	0.00184	0.0101	CbGpPWpGaD
Olopatadine—Dysgeusia—Metformin—metabolic syndrome X	0.00181	0.0301	CcSEcCtD
Olopatadine—Clomipramine—ALB—metabolic syndrome X	0.00181	0.0498	CrCbGaD
Olopatadine—Muscle spasms—Metformin—metabolic syndrome X	0.00178	0.0296	CcSEcCtD
Olopatadine—S100A12—Innate Immune System—LBP—metabolic syndrome X	0.00177	0.00971	CbGpPWpGaD
Olopatadine—Nortriptyline—ALB—metabolic syndrome X	0.00177	0.0486	CrCbGaD
Olopatadine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I3—metabolic syndrome X	0.00175	0.00959	CbGpPWpGaD
Olopatadine—Vision blurred—Metformin—metabolic syndrome X	0.00175	0.029	CcSEcCtD
Olopatadine—Ill-defined disorder—Metformin—metabolic syndrome X	0.00172	0.0285	CcSEcCtD
Olopatadine—S100B—Innate Immune System—LBP—metabolic syndrome X	0.00168	0.00918	CbGpPWpGaD
Olopatadine—Malaise—Metformin—metabolic syndrome X	0.00167	0.0277	CcSEcCtD
Olopatadine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—metabolic syndrome X	0.0016	0.00877	CbGpPWpGaD
Olopatadine—Unspecified disorder of skin and subcutaneous tissue—Metformin—metabolic syndrome X	0.00157	0.026	CcSEcCtD
Olopatadine—Discomfort—Metformin—metabolic syndrome X	0.00156	0.0259	CcSEcCtD
Olopatadine—Oedema—Metformin—metabolic syndrome X	0.00151	0.0251	CcSEcCtD
Olopatadine—S100B—Signaling by ERBB4—IRS1—metabolic syndrome X	0.0015	0.00822	CbGpPWpGaD
Olopatadine—Infection—Metformin—metabolic syndrome X	0.0015	0.0249	CcSEcCtD
Olopatadine—Nervous system disorder—Metformin—metabolic syndrome X	0.00148	0.0246	CcSEcCtD
Olopatadine—Skin disorder—Metformin—metabolic syndrome X	0.00147	0.0244	CcSEcCtD
Olopatadine—S100A12—Innate Immune System—PLA2G6—metabolic syndrome X	0.00146	0.00799	CbGpPWpGaD
Olopatadine—CYP3A4—Aflatoxin activation and detoxification—GGT1—metabolic syndrome X	0.00142	0.00777	CbGpPWpGaD
Olopatadine—S100B—Innate Immune System—PLA2G6—metabolic syndrome X	0.00138	0.00756	CbGpPWpGaD
Olopatadine—Dyspnoea—Metformin—metabolic syndrome X	0.00135	0.0224	CcSEcCtD
Olopatadine—S100A12—Innate Immune System—TRIB3—metabolic syndrome X	0.00134	0.00736	CbGpPWpGaD
Olopatadine—Somnolence—Metformin—metabolic syndrome X	0.00134	0.0223	CcSEcCtD
Olopatadine—CYP3A4—Phase 1 - Functionalization of compounds—FMO3—metabolic syndrome X	0.00134	0.00731	CbGpPWpGaD
Olopatadine—Gastrointestinal disorder—Metformin—metabolic syndrome X	0.00131	0.0217	CcSEcCtD
Olopatadine—Fatigue—Metformin—metabolic syndrome X	0.0013	0.0216	CcSEcCtD
Olopatadine—S100B—Innate Immune System—TRIB3—metabolic syndrome X	0.00127	0.00696	CbGpPWpGaD
Olopatadine—Feeling abnormal—Metformin—metabolic syndrome X	0.00125	0.0207	CcSEcCtD
Olopatadine—Gastrointestinal pain—Metformin—metabolic syndrome X	0.00124	0.0205	CcSEcCtD
Olopatadine—Amitriptyline—ALB—metabolic syndrome X	0.00123	0.0337	CrCbGaD
Olopatadine—Abdominal pain—Metformin—metabolic syndrome X	0.0012	0.0198	CcSEcCtD
Olopatadine—S100A12—TRAF6 Mediated Induction of proinflammatory cytokines—IL6—metabolic syndrome X	0.00117	0.0064	CbGpPWpGaD
Olopatadine—S100B—TRAF6 Mediated Induction of proinflammatory cytokines—IL6—metabolic syndrome X	0.00111	0.00606	CbGpPWpGaD
Olopatadine—Asthenia—Metformin—metabolic syndrome X	0.00109	0.018	CcSEcCtD
Olopatadine—Pruritus—Metformin—metabolic syndrome X	0.00107	0.0178	CcSEcCtD
Olopatadine—S100A12—MyD88 cascade initiated on plasma membrane—IL6—metabolic syndrome X	0.00106	0.00579	CbGpPWpGaD
Olopatadine—S100A12—TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation—IL6—metabolic syndrome X	0.00105	0.00574	CbGpPWpGaD
Olopatadine—Diarrhoea—Metformin—metabolic syndrome X	0.00103	0.0172	CcSEcCtD
Olopatadine—S100A12—Immune System—LBP—metabolic syndrome X	0.00103	0.00565	CbGpPWpGaD
Olopatadine—S100A12—MyD88 dependent cascade initiated on endosome—IL6—metabolic syndrome X	0.00103	0.00564	CbGpPWpGaD
Olopatadine—S100B—MyD88 cascade initiated on plasma membrane—IL6—metabolic syndrome X	0.001	0.00548	CbGpPWpGaD
Olopatadine—Dizziness—Metformin—metabolic syndrome X	0.001	0.0166	CcSEcCtD
Olopatadine—S100A12—Toll Like Receptor 9 (TLR9) Cascade—IL6—metabolic syndrome X	0.000994	0.00544	CbGpPWpGaD
Olopatadine—S100B—TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation—IL6—metabolic syndrome X	0.000992	0.00543	CbGpPWpGaD
Olopatadine—S100B—Immune System—LBP—metabolic syndrome X	0.000977	0.00535	CbGpPWpGaD
Olopatadine—S100A12—MyD88:Mal cascade initiated on plasma membrane—IL6—metabolic syndrome X	0.000977	0.00535	CbGpPWpGaD
Olopatadine—S100B—MyD88 dependent cascade initiated on endosome—IL6—metabolic syndrome X	0.000974	0.00533	CbGpPWpGaD
Olopatadine—Vomiting—Metformin—metabolic syndrome X	0.000962	0.016	CcSEcCtD
Olopatadine—HRH1—IL-4 Signaling Pathway—IRS1—metabolic syndrome X	0.000961	0.00526	CbGpPWpGaD
Olopatadine—Rash—Metformin—metabolic syndrome X	0.000954	0.0158	CcSEcCtD
Olopatadine—Dermatitis—Metformin—metabolic syndrome X	0.000953	0.0158	CcSEcCtD
Olopatadine—Headache—Metformin—metabolic syndrome X	0.000947	0.0157	CcSEcCtD
Olopatadine—S100B—Toll Like Receptor 9 (TLR9) Cascade—IL6—metabolic syndrome X	0.00094	0.00514	CbGpPWpGaD
Olopatadine—S100A12—MyD88-independent cascade—IL6—metabolic syndrome X	0.000938	0.00513	CbGpPWpGaD
Olopatadine—S100B—MyD88:Mal cascade initiated on plasma membrane—IL6—metabolic syndrome X	0.000924	0.00506	CbGpPWpGaD
Olopatadine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—metabolic syndrome X	0.000921	0.00504	CbGpPWpGaD
Olopatadine—Nausea—Metformin—metabolic syndrome X	0.000898	0.0149	CcSEcCtD
Olopatadine—S100B—MyD88-independent cascade—IL6—metabolic syndrome X	0.000887	0.00485	CbGpPWpGaD
Olopatadine—S100A12—Immune System—PLA2G6—metabolic syndrome X	0.000851	0.00466	CbGpPWpGaD
Olopatadine—S100A12—Activated TLR4 signalling—IL6—metabolic syndrome X	0.000843	0.00461	CbGpPWpGaD
Olopatadine—S100B—Immune System—PLA2G6—metabolic syndrome X	0.000805	0.0044	CbGpPWpGaD
Olopatadine—S100B—Activated TLR4 signalling—IL6—metabolic syndrome X	0.000798	0.00436	CbGpPWpGaD
Olopatadine—S100A12—Toll Like Receptor 4 (TLR4) Cascade—IL6—metabolic syndrome X	0.000793	0.00434	CbGpPWpGaD
Olopatadine—S100A12—Immune System—TRIB3—metabolic syndrome X	0.000783	0.00428	CbGpPWpGaD
Olopatadine—S100B—Toll Like Receptor 4 (TLR4) Cascade—IL6—metabolic syndrome X	0.00075	0.0041	CbGpPWpGaD
Olopatadine—S100B—Immune System—TRIB3—metabolic syndrome X	0.000741	0.00405	CbGpPWpGaD
Olopatadine—CYP3A4—Biological oxidations—FMO3—metabolic syndrome X	0.00071	0.00388	CbGpPWpGaD
Olopatadine—S100A12—Toll-Like Receptors Cascades—IL6—metabolic syndrome X	0.000707	0.00386	CbGpPWpGaD
Olopatadine—CYP3A4—Metapathway biotransformation—FMO3—metabolic syndrome X	0.0007	0.00383	CbGpPWpGaD
Olopatadine—HRH1—G alpha (q) signalling events—HTR2C—metabolic syndrome X	0.000699	0.00383	CbGpPWpGaD
Olopatadine—S100A12—Innate Immune System—CD36—metabolic syndrome X	0.000695	0.0038	CbGpPWpGaD
Olopatadine—HRH1—GPCRs, Class A Rhodopsin-like—MTNR1B—metabolic syndrome X	0.000694	0.0038	CbGpPWpGaD
Olopatadine—S100B—Toll-Like Receptors Cascades—IL6—metabolic syndrome X	0.000668	0.00365	CbGpPWpGaD
Olopatadine—HRH1—G alpha (q) signalling events—GHRL—metabolic syndrome X	0.000663	0.00363	CbGpPWpGaD
Olopatadine—S100B—Innate Immune System—CD36—metabolic syndrome X	0.000657	0.00359	CbGpPWpGaD
Olopatadine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARA—metabolic syndrome X	0.000638	0.00349	CbGpPWpGaD
Olopatadine—S100B—Signaling by ERBB4—IL6—metabolic syndrome X	0.000629	0.00344	CbGpPWpGaD
Olopatadine—S100A12—Innate Immune System—CRP—metabolic syndrome X	0.000626	0.00343	CbGpPWpGaD
Olopatadine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2C—metabolic syndrome X	0.000625	0.00342	CbGpPWpGaD
Olopatadine—CYP3A4—Metapathway biotransformation—EPHX2—metabolic syndrome X	0.000624	0.00341	CbGpPWpGaD
Olopatadine—S100A12—Immune System—CYBA—metabolic syndrome X	0.000606	0.00332	CbGpPWpGaD
Olopatadine—HRH1—Class A/1 (Rhodopsin-like receptors)—MTNR1B—metabolic syndrome X	0.000594	0.00325	CbGpPWpGaD
Olopatadine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—GHRL—metabolic syndrome X	0.000593	0.00324	CbGpPWpGaD
Olopatadine—S100B—Innate Immune System—CRP—metabolic syndrome X	0.000592	0.00324	CbGpPWpGaD
Olopatadine—S100B—Signaling by ERBB4—AKT1—metabolic syndrome X	0.00058	0.00318	CbGpPWpGaD
Olopatadine—S100B—Immune System—CYBA—metabolic syndrome X	0.000573	0.00314	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—HDAC3—metabolic syndrome X	0.00055	0.00301	CbGpPWpGaD
Olopatadine—S100A12—Innate Immune System—IRS1—metabolic syndrome X	0.000547	0.00299	CbGpPWpGaD
Olopatadine—HRH1—GPCRs, Class A Rhodopsin-like—HTR2C—metabolic syndrome X	0.000541	0.00296	CbGpPWpGaD
Olopatadine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—metabolic syndrome X	0.000528	0.00289	CbGpPWpGaD
Olopatadine—S100B—Innate Immune System—IRS1—metabolic syndrome X	0.000517	0.00283	CbGpPWpGaD
Olopatadine—S100A12—Immune System—VCAM1—metabolic syndrome X	0.000493	0.00269	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—MTNR1B—metabolic syndrome X	0.000491	0.00269	CbGpPWpGaD
Olopatadine—HRH1—GPCRs, Class A Rhodopsin-like—CNR1—metabolic syndrome X	0.000485	0.00265	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—RBP4—metabolic syndrome X	0.000479	0.00262	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—TRIB3—metabolic syndrome X	0.000479	0.00262	CbGpPWpGaD
Olopatadine—S100B—Immune System—VCAM1—metabolic syndrome X	0.000466	0.00255	CbGpPWpGaD
Olopatadine—HRH1—Class A/1 (Rhodopsin-like receptors)—HTR2C—metabolic syndrome X	0.000463	0.00253	CbGpPWpGaD
Olopatadine—HRH1—GPCR ligand binding—MTNR1B—metabolic syndrome X	0.000453	0.00248	CbGpPWpGaD
Olopatadine—HRH1—Class A/1 (Rhodopsin-like receptors)—GHRL—metabolic syndrome X	0.000439	0.0024	CbGpPWpGaD
Olopatadine—S100A12—Immune System—IL18—metabolic syndrome X	0.000436	0.00238	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—APOC3—metabolic syndrome X	0.000424	0.00232	CbGpPWpGaD
Olopatadine—HRH1—Class A/1 (Rhodopsin-like receptors)—CNR1—metabolic syndrome X	0.000416	0.00227	CbGpPWpGaD
Olopatadine—S100B—Immune System—IL18—metabolic syndrome X	0.000412	0.00225	CbGpPWpGaD
Olopatadine—HRH1—G alpha (q) signalling events—AGT—metabolic syndrome X	0.000407	0.00223	CbGpPWpGaD
Olopatadine—S100A12—Immune System—CD36—metabolic syndrome X	0.000405	0.00221	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—HTR2C—metabolic syndrome X	0.000383	0.00209	CbGpPWpGaD
Olopatadine—S100B—Immune System—CD36—metabolic syndrome X	0.000383	0.00209	CbGpPWpGaD
Olopatadine—HRH1—IL-4 Signaling Pathway—AKT1—metabolic syndrome X	0.000371	0.00203	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—CYBA—metabolic syndrome X	0.000371	0.00203	CbGpPWpGaD
Olopatadine—S100A12—Immune System—CRP—metabolic syndrome X	0.000365	0.002	CbGpPWpGaD
Olopatadine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—AGT—metabolic syndrome X	0.000364	0.00199	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—GHRL—metabolic syndrome X	0.000363	0.00199	CbGpPWpGaD
Olopatadine—HRH1—GPCR ligand binding—HTR2C—metabolic syndrome X	0.000353	0.00193	CbGpPWpGaD
Olopatadine—S100B—Immune System—CRP—metabolic syndrome X	0.000345	0.00189	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—CNR1—metabolic syndrome X	0.000344	0.00188	CbGpPWpGaD
Olopatadine—HRH1—GPCR ligand binding—GHRL—metabolic syndrome X	0.000334	0.00183	CbGpPWpGaD
Olopatadine—HRH1—Class A/1 (Rhodopsin-like receptors)—CCL5—metabolic syndrome X	0.000322	0.00176	CbGpPWpGaD
Olopatadine—S100A12—Immune System—IRS1—metabolic syndrome X	0.000319	0.00174	CbGpPWpGaD
Olopatadine—HRH1—GPCR ligand binding—CNR1—metabolic syndrome X	0.000317	0.00173	CbGpPWpGaD
Olopatadine—S100B—Immune System—IRS1—metabolic syndrome X	0.000301	0.00165	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—IGF2—metabolic syndrome X	0.000281	0.00154	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—APOB—metabolic syndrome X	0.000273	0.00149	CbGpPWpGaD
Olopatadine—HRH1—Class A/1 (Rhodopsin-like receptors)—AGT—metabolic syndrome X	0.00027	0.00147	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—CCL5—metabolic syndrome X	0.000266	0.00146	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—PLA2G4A—metabolic syndrome X	0.000265	0.00145	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—LPL—metabolic syndrome X	0.00026	0.00142	CbGpPWpGaD
Olopatadine—HRH1—GPCR downstream signaling—MTNR1B—metabolic syndrome X	0.000256	0.0014	CbGpPWpGaD
Olopatadine—HRH1—GPCR ligand binding—CCL5—metabolic syndrome X	0.000245	0.00134	CbGpPWpGaD
Olopatadine—CYP3A4—Biological oxidations—GGT1—metabolic syndrome X	0.000244	0.00133	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—MTNR1B—metabolic syndrome X	0.000232	0.00127	CbGpPWpGaD
Olopatadine—S100A12—Innate Immune System—IL6—metabolic syndrome X	0.000229	0.00125	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—AGT—metabolic syndrome X	0.000223	0.00122	CbGpPWpGaD
Olopatadine—HRH1—Class A/1 (Rhodopsin-like receptors)—CCL2—metabolic syndrome X	0.000222	0.00121	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—APOE—metabolic syndrome X	0.000218	0.00119	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—LEP—metabolic syndrome X	0.000218	0.00119	CbGpPWpGaD
Olopatadine—S100B—Innate Immune System—IL6—metabolic syndrome X	0.000216	0.00118	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—APOA1—metabolic syndrome X	0.000216	0.00118	CbGpPWpGaD
Olopatadine—S100A12—Innate Immune System—AKT1—metabolic syndrome X	0.000211	0.00115	CbGpPWpGaD
Olopatadine—HRH1—GPCR ligand binding—AGT—metabolic syndrome X	0.000205	0.00112	CbGpPWpGaD
Olopatadine—S100B—Innate Immune System—AKT1—metabolic syndrome X	0.0002	0.00109	CbGpPWpGaD
Olopatadine—HRH1—GPCR downstream signaling—HTR2C—metabolic syndrome X	0.000199	0.00109	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—IRS1—metabolic syndrome X	0.000195	0.00107	CbGpPWpGaD
Olopatadine—HRH1—GPCR downstream signaling—GHRL—metabolic syndrome X	0.000189	0.00103	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—INS—metabolic syndrome X	0.000187	0.00102	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—CCL2—metabolic syndrome X	0.000183	0.001	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—HTR2C—metabolic syndrome X	0.000181	0.00099	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—IGF1—metabolic syndrome X	0.00018	0.000987	CbGpPWpGaD
Olopatadine—HRH1—GPCR downstream signaling—CNR1—metabolic syndrome X	0.000179	0.000979	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—GHRL—metabolic syndrome X	0.000172	0.000939	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—SERPINE1—metabolic syndrome X	0.000171	0.000937	CbGpPWpGaD
Olopatadine—HRH1—GPCR ligand binding—CCL2—metabolic syndrome X	0.000169	0.000925	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—NOS3—metabolic syndrome X	0.000164	0.000895	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—CNR1—metabolic syndrome X	0.000162	0.000889	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—HDAC3—metabolic syndrome X	0.000154	0.00084	CbGpPWpGaD
Olopatadine—HRH1—GPCR downstream signaling—CCL5—metabolic syndrome X	0.000139	0.000759	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—MTNR1B—metabolic syndrome X	0.000137	0.000751	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—RBP4—metabolic syndrome X	0.000134	0.000732	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—TRIB3—metabolic syndrome X	0.000134	0.000732	CbGpPWpGaD
Olopatadine—S100A12—Immune System—IL6—metabolic syndrome X	0.000133	0.000729	CbGpPWpGaD
Olopatadine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—metabolic syndrome X	0.000133	0.000728	CbGpPWpGaD
Olopatadine—S100B—Immune System—IL6—metabolic syndrome X	0.000126	0.00069	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—CCL5—metabolic syndrome X	0.000126	0.000689	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—PLA2G4A—metabolic syndrome X	0.000125	0.000686	CbGpPWpGaD
Olopatadine—S100A12—Immune System—AKT1—metabolic syndrome X	0.000123	0.000673	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—FMO3—metabolic syndrome X	0.000121	0.000664	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—APOC3—metabolic syndrome X	0.000118	0.000648	CbGpPWpGaD
Olopatadine—S100B—Immune System—AKT1—metabolic syndrome X	0.000116	0.000636	CbGpPWpGaD
Olopatadine—HRH1—GPCR downstream signaling—AGT—metabolic syndrome X	0.000116	0.000635	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—EPHX2—metabolic syndrome X	0.000108	0.000592	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—MLXIPL—metabolic syndrome X	0.000108	0.000592	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—TGFB1—metabolic syndrome X	0.000108	0.000592	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—HTR2C—metabolic syndrome X	0.000107	0.000585	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—AGT—metabolic syndrome X	0.000105	0.000576	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—CYBA—metabolic syndrome X	0.000104	0.000566	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—G6PC2—metabolic syndrome X	0.000102	0.000556	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—GHRL—metabolic syndrome X	0.000101	0.000554	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—CNR1—metabolic syndrome X	9.6e-05	0.000525	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—CCL2—metabolic syndrome X	8.68e-05	0.000475	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—FABP4—metabolic syndrome X	8.65e-05	0.000473	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—HSD11B1—metabolic syndrome X	8.2e-05	0.000448	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—IL6—metabolic syndrome X	8.15e-05	0.000446	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—IGF2—metabolic syndrome X	7.85e-05	0.000429	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—APOB—metabolic syndrome X	7.62e-05	0.000417	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—AKT1—metabolic syndrome X	7.52e-05	0.000411	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—CCL5—metabolic syndrome X	7.44e-05	0.000407	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—PLA2G4A—metabolic syndrome X	7.41e-05	0.000405	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—G6PD—metabolic syndrome X	7.31e-05	0.0004	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—LPL—metabolic syndrome X	7.27e-05	0.000398	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—HDAC3—metabolic syndrome X	7.13e-05	0.00039	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—GCKR—metabolic syndrome X	6.97e-05	0.000381	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—LPA—metabolic syndrome X	6.97e-05	0.000381	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—PLA2G6—metabolic syndrome X	6.75e-05	0.000369	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—APOA5—metabolic syndrome X	6.68e-05	0.000366	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—AGT—metabolic syndrome X	6.22e-05	0.00034	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—TRIB3—metabolic syndrome X	6.21e-05	0.00034	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—LEP—metabolic syndrome X	6.1e-05	0.000334	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—APOE—metabolic syndrome X	6.1e-05	0.000334	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—APOA1—metabolic syndrome X	6.03e-05	0.00033	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—NAMPT—metabolic syndrome X	5.57e-05	0.000305	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—LIPC—metabolic syndrome X	5.54e-05	0.000303	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—GCK—metabolic syndrome X	5.54e-05	0.000303	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—APOC3—metabolic syndrome X	5.5e-05	0.000301	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—IRS1—metabolic syndrome X	5.44e-05	0.000298	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—CETP—metabolic syndrome X	5.34e-05	0.000292	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—INS—metabolic syndrome X	5.21e-05	0.000285	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—CCL2—metabolic syndrome X	5.12e-05	0.00028	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—SCARB1—metabolic syndrome X	5.12e-05	0.00028	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—IGF1—metabolic syndrome X	5.04e-05	0.000276	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—SREBF1—metabolic syndrome X	4.97e-05	0.000272	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—HMGCR—metabolic syndrome X	4.83e-05	0.000264	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—GOT2—metabolic syndrome X	4.83e-05	0.000264	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—SERPINE1—metabolic syndrome X	4.78e-05	0.000262	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—NOS3—metabolic syndrome X	4.57e-05	0.00025	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—SLC2A4—metabolic syndrome X	4.31e-05	0.000236	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—ABCA1—metabolic syndrome X	4.31e-05	0.000236	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—GGT1—metabolic syndrome X	4.17e-05	0.000228	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—GOT1—metabolic syndrome X	4.17e-05	0.000228	CbGpPWpGaD
Olopatadine—HRH1—GPCR downstream signaling—AKT1—metabolic syndrome X	3.91e-05	0.000214	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—IL6—metabolic syndrome X	3.85e-05	0.000211	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—AKT1—metabolic syndrome X	3.55e-05	0.000194	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—APOB—metabolic syndrome X	3.54e-05	0.000194	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—PLA2G4A—metabolic syndrome X	3.44e-05	0.000188	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—LPL—metabolic syndrome X	3.38e-05	0.000185	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—CD36—metabolic syndrome X	3.21e-05	0.000176	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—TGFB1—metabolic syndrome X	3.02e-05	0.000165	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—PPARA—metabolic syndrome X	2.98e-05	0.000163	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—AGT—metabolic syndrome X	2.89e-05	0.000158	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—APOE—metabolic syndrome X	2.83e-05	0.000155	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—APOA1—metabolic syndrome X	2.8e-05	0.000153	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—PPARG—metabolic syndrome X	2.47e-05	0.000135	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—INS—metabolic syndrome X	2.42e-05	0.000132	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—IL6—metabolic syndrome X	2.28e-05	0.000125	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—ALB—metabolic syndrome X	2.22e-05	0.000121	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—NOS3—metabolic syndrome X	2.12e-05	0.000116	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—AKT1—metabolic syndrome X	2.1e-05	0.000115	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—PTGS2—metabolic syndrome X	1.94e-05	0.000106	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—AKT1—metabolic syndrome X	9.75e-06	5.34e-05	CbGpPWpGaD
